Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer
Clinical trial NCT02467569 · TERMINATED
Trial details
- NCT number
- NCT02467569
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-03
- Primary completion
- 2017-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.